IL6 and pulmonary fibrosis: In the current study, we observed the upregulation of retinol-metabolizing pathway molecules, recovery of the expression of RALDH, and suppressed expression of IL-6 and TGF-β in BLM-induced pulmonary fibrosis treated with CD45−/ALDHbr cell therapy.